Ally Therapeutics
Ally Therapeutics was an American biotechnology company based in Cambridge, Massachusetts. It was founded in 2018 and shut down in September 2021.1)
History
Ally Therapeutics was spun out from George Church's lab at Harvard University in 2018. The company focused on developing “less immunogenic gene therapies”.2) It received funding through Springboard Enterprises' Health Innovation Hub: Life Science in 2018.3)
In July 2019, the company secured seed financing from Alta Partners, ARCH Venture Partners and UCB Ventures.4)
External links
1)
Ally Therapeutics shuts down. Global Venturing. Retrieved March 5, 2023, from https://archive.ph/dRkpQ
2)
Ally Therapeutics. (2019, July 31). UCB Ventures. https://web.archive.org/web/20200922143412/https://ucbventures.com/sites/default/files/news-articles/Ally_Therapeutics_31_July_2019.pdf
3)
Portfolio. Springboard Enterprises. Retrieved December 14, 2022, from https://web.archive.org/web/20221214113825/https://sb.co/portfolio/
4)
Liu, A. (2021, February 10). Biotech entrepreneur George Church launches gene therapy startup to design safer viral vectors. FierceBiotech. https://web.archive.org/web/20230305023409/https://www.fiercebiotech.com/research/george-church-s-new-gene-therapy-project-shields-viral-vectors-from-problematic-immune